Stanford University has been selected as a partner by the Wallace H. Coulter Foundation, which supports collaborative translational research projects through an award to Bioengineering, one of nine such awards nationwide.
The Stanford-Coulter Translational Research Grants Program awards up to $800,000 a year to Bioengineering faculty members and their clinician researcher collaborators from the School of Medicine. Together, these teams of co-investigators work to develop new technologies that address unmet clinical needs, improve health care and lead to commercially available products.
Stanford University brings together top-notch clinical research and a tradition of innovation on its campus in the heart of Silicon Valley, the technology capital of the world. This unique position, along with support from the Coulter foundation, will allow awardees to quickly and expertly meet the challenges and needs facing medicine today.
Grants will be for a one-year period and may be submitted for renewal the following year. Renewal applications must have a comparison of milestones achieved vs. those planned in the original submission. Renewal applications will be evaluated on a competitive basis using the same process as with new applications. Intellectual property of core technology must be owned by Stanford (not under an option or license to any entity). Funding will not be dispersed without clearance of any applicable APLAC, IRB or IRB exemption requirements.
Each proposal must have at least two co-principal investigators:
one with a full, joint, or courtesy UTL, MCL, and NTL-Research faculty appointment in the Department of Bioengineering at Stanford
and at least one with a full, joint, or courtesy UTL, MCL, NTL-Research or Clinician Educator faculty appointment in a clinical department in the School of Medicine
other team members (grad students, postdocs, research staff, etc.) may be listed on the proposal
Intellectual property of core technology must be owned by Stanford (unlicensed to outside entity)
A PDRF is not due at the time of proposal submission, however, in the event the proposal advances to the finalist screening stage, a PDRF will be required prior to the finalist presentations in March, 2019.
Funding will not be dispersed without clearance of any applicable APLAC, IRB or IRB exemption requirements.
Maximum funding amount:
How can the funds be used?
Grants may be requested for up to $100,000 direct costs for one year.
Funds may be used for salary support of graduate students and other research staff, but may not be used for general staff, administrative support or tuition.
Operating supplies, equipment items, prototyping expenses, imaging time and travel directly associated with the research activity are examples of eligible budget items.
Budget details should include general categories such as personnel, supplies, travel, non-capital equipment and other project related expenses.